Goglia AG, Alshalalfa M, Khan A, Isakov DR, et al. Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. J Natl Cancer Inst 2025;117:188-197.
PMID: 39254651